180 related articles for article (PubMed ID: 34521110)
21. Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship.
Selvakumar S; Liu A; Chaturvedi S
Front Med (Lausanne); 2023; 10():1137019. PubMed ID: 36926315
[TBL] [Abstract][Full Text] [Related]
22. Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.
Jestin M; Benhamou Y; Schelpe AS; Roose E; Provôt F; Galicier L; Hié M; Presne C; Poullin P; Wynckel A; Saheb S; Deligny C; Servais A; Girault S; Delmas Y; Kanouni T; Lautrette A; Chauveau D; Mousson C; Perez P; Halimi JM; Charvet-Rumpler A; Hamidou M; Cathébras P; Vanhoorelbeke K; Veyradier A; Coppo P;
Blood; 2018 Nov; 132(20):2143-2153. PubMed ID: 30201758
[TBL] [Abstract][Full Text] [Related]
23. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
[TBL] [Abstract][Full Text] [Related]
24. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
25. Plasma Levels of Big Endothelin-1 Are Associated with Renal Insufficiency and In-Hospital Mortality of Immune Thrombotic Thrombocytopenic Purpura.
Lu R; Zheng XL
Thromb Haemost; 2022 Mar; 122(3):344-352. PubMed ID: 33984867
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of immune-mediated thrombotic thrombocytopenic purpura: A decisive turning point].
Poullin P
Transfus Clin Biol; 2021 Nov; 28(4):380-385. PubMed ID: 34464709
[TBL] [Abstract][Full Text] [Related]
27. Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab.
Falter T; Herold S; Weyer-Elberich V; Scheiner C; Schmitt V; von Auer C; Messmer X; Wild P; Lackner KJ; Lämmle B; Scharrer I
Thromb Haemost; 2018 Oct; 118(10):1743-1751. PubMed ID: 30235478
[TBL] [Abstract][Full Text] [Related]
28. Caplacizumab: a change in the paradigm of thrombotic thrombocytopenic purpura treatment.
le Besnerais M; Veyradier A; Benhamou Y; Coppo P
Expert Opin Biol Ther; 2019 Nov; 19(11):1127-1134. PubMed ID: 31359806
[No Abstract] [Full Text] [Related]
29. Health following recovery from immune thrombotic thrombocytopenic purpura: the patient's perspective.
Kelley RA; Cheney MK; Martin CM; Cataland S; Quick LB; Keller S; Vesely SK; Llaneza AJ; Khawandanah MO; Journeycake JM; Panepinto JA; Terrell DR
Blood Adv; 2023 May; 7(9):1813-1822. PubMed ID: 36287218
[TBL] [Abstract][Full Text] [Related]
30. Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura.
Kayashima M; Sakai K; Harada K; Kanetake J; Kubo M; Hamada E; Hayakawa M; Hatakeyama K; Matsumoto M
Int J Hematol; 2021 Oct; 114(4):415-423. PubMed ID: 34292506
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
32. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
33. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
Letchumanan P; Ng HJ; Lee LH; Thumboo J
Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.
Adeyemi A; Razakariasa F; Chiorean A; de Passos Sousa R
Res Pract Thromb Haemost; 2022 Aug; 6(6):e12802. PubMed ID: 36176310
[TBL] [Abstract][Full Text] [Related]
35. Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by Influenza A (H1N1) Virus Successfully Treated by Plasma Exchange: A Case Report.
Kubo K; Abe T; Kawano N; Ochiai H
Am J Case Rep; 2021 Aug; 22():e932251. PubMed ID: 34334786
[TBL] [Abstract][Full Text] [Related]
36. Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
Schieppati F; Russo L; Marchetti M; Barcella L; Cefis M; Gomez-Rosas P; Caldara G; Carpenedo M; D'Adda M; Rambaldi A; Savignano C; Billio A; Bruno Franco M; Toschi V; Falanga A
Am J Hematol; 2020 Aug; 95(8):953-959. PubMed ID: 32350923
[TBL] [Abstract][Full Text] [Related]
37. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
Al-Husban N; Al-Kuran O
J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission.
Sukumar S; Brodsky M; Hussain S; Yanek L; Moliterno A; Brodsky R; Cataland SR; Chaturvedi S
Blood Adv; 2022 Feb; 6(4):1264-1270. PubMed ID: 34461629
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura.
Stubbs MJ; Coppo P; Cheshire C; Veyradier A; Dufek S; Levine AP; Thomas M; Patel V; Connolly JO; Hubank M; Benhamou Y; Galicier L; Poullin P; Kleta R; Gale DP; Stanescu H; Scully MA
Haematologica; 2022 Mar; 107(3):574-582. PubMed ID: 33596643
[TBL] [Abstract][Full Text] [Related]
40. Early plasmapheresis in patients with thrombotic thrombocytopenic purpura.
Douzinas EE; Markakis K; Karabinis A; Mandalaki T; Bilalis D; Fessas P
Crit Care Med; 1992 Jan; 20(1):57-61. PubMed ID: 1729046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
